| 来源类型 | Publication |
| The PHS 340B Drug Pricing Program: Results of a Survey of Eligible Entities | |
| Robert Schmitz; So Limpa-Amara; Julita Milliner-Waddell,; Frank Potter | |
| 发表日期 | 2004-08-30 |
| 出版者 | Cambridge, MA: Mathematica Policy Research |
| 出版年 | 2004 |
| 语种 | 英语 |
| 概述 | Escalating drug prices have affected safety net providers in serious ways. ", |
| 摘要 | Escalating drug prices have affected safety net providers in serious ways. This report studies providers eligible to purchase prescription drugs at a discount under the 340B program, which requires manufacturers that receive reimbursement from Medicaid to provide reduced prices to more than 10,000 qualified health care clinics, centers, and hospitals in the U.S. These providers in turn serve more than 10 million people in all 50 states. The findings suggest that the program has led to significant savings and a high level of satisfaction for providers enrolled in it. In its absence, providers would probably serve fewer patients, charge higher prices for prescription drugs, and incur greater losses. |
| URL | https://www.mathematica.org/our-publications-and-findings/publications/the-phs-340b-drug-pricing-program-results-of-a-survey-of-eligible-entities |
| 来源智库 | Mathematica Policy Research (United States) |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/485269 |
| 推荐引用方式 GB/T 7714 | Robert Schmitz,So Limpa-Amara,Julita Milliner-Waddell,,et al. The PHS 340B Drug Pricing Program: Results of a Survey of Eligible Entities. 2004. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| 340Bsurveyrpt.pdf（391KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
